Analystreport

Clementia Pharmaceuticals Inc (NASDAQ: CMTA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.

CLEMENTIA PHARMACEUTICALS INC COMMON SHARES  (CMTA) 
Last clementia pharmaceuticals inc common shares earnings: 11/7 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.clementiapharma.com/investor-relations